论文部分内容阅读
目的:分析经尿道膀胱肿瘤电切术联合膀胱灌注对膀胱肿瘤的治疗价值。方法:选择我院2014年6月-2016年6月间参与择期手术的膀胱肿瘤患者44例,利用随机分配的方式,分为实验组和对照组,每组患者为22例,其中实验组患者行经尿道膀胱肿瘤电切术联合膀胱灌注,对照组患者行经尿道膀胱肿瘤电切术,对比分析两组患者临床治疗效果。结果:对照组患者不良反应为27.27%、总复发率为45.45%;实验组患者不良反应为4.55%、总复发率为13.64%,两组患者各数据间存在差异,具有统计学意义,P<0.05。结论:经尿道膀胱肿瘤电切术联合膀胱灌注治疗膀胱肿瘤疾病,可有效提升患者临床治愈率,延长患者生命周期,具有显著优势。
Objective: To analyze the value of transurethral resection of bladder tumor combined with intravesical instillation of bladder tumor. Methods: Forty-four patients with bladder cancer who participated in elective surgery from June 2014 to June 2016 in our hospital were randomly divided into experimental group and control group, with 22 patients in each group. The patients in experimental group Transurethral resection of the bladder tumor combined with intravesical instillation, the control group of patients with transurethral resection of the bladder tumor, comparative analysis of two groups of patients with clinical treatment. Results: The adverse reactions of the control group were 27.27% and the total recurrence rate was 45.45%. The adverse reactions in the experimental group were 4.55% and the total recurrence rate was 13.64%. There was significant difference between the two groups of patients with statistical significance (P < 0.05. Conclusion: Transurethral resection of bladder tumor combined with intravesical instillation of bladder tumor can effectively improve the clinical cure rate and prolong the life cycle of patients with significant advantages.